# ClinicalTrials.gov record NCT06445075

> PeptideScanner retained ClinicalTrials.gov record NCT06445075 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06445075-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06445075-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06445075-tirzepatide-v1.json
- Content SHA-256: `2f18772a1305f41699e839c49772158855d243e8d732923052b141ce33b743f6`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06445075 ([`ctg-observation-nct06445075-2026-01-23-263be8f36b29`](#source-ctg-observation-nct06445075-2026-01-23-263be8f36b29))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06445075 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06445075-2026-01-23-263be8f36b29`](#source-ctg-observation-nct06445075-2026-01-23-263be8f36b29))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06445075 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06445075-2026-01-23-263be8f36b29`](#source-ctg-observation-nct06445075-2026-01-23-263be8f36b29))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06445075-2026-01-23-263be8f36b29`](#source-ctg-observation-nct06445075-2026-01-23-263be8f36b29))

## Sources

<a id="source-ctg-observation-nct06445075-2026-01-23-263be8f36b29"></a>
- **ClinicalTrials.gov record NCT06445075 · retained source version 2026-01-23:263be8f36b29016c742285892ecf1468cd73d97dd102c3f27d97917aea41a0c2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06445075) (`ctg-observation-nct06445075-2026-01-23-263be8f36b29`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06445075." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06445075-tirzepatide-v1.json SHA-256: 2f18772a1305f41699e839c49772158855d243e8d732923052b141ce33b743f6.